Literature DB >> 12626412

The effects of ethanol on the glycosylation of human transferrin.

C Flahaut1, J C Michalski, T Danel, M H Humbert, A Klein.   

Abstract

Appearance of a hyposialylated transferrin fraction in the plasma during chronic alcohol exposure is a well-known phenomenon, and it represents the best available marker of chronic alcohol consumption. The mechanisms of its appearance are still not well understood and are extremely complex, involving biosynthesis and catabolism alterations, although the only structural abnormality described corresponds to the loss of an entire glycan chain. We analyzed and compared the oligosaccharides present on the different isoforms of purified transferrin isolated from control and patients with severe alcohol abuse by fluorescent carbohydrate electrophoresis and matrix-assisted laser desorption ionization mass spectrometry. Our data indicate that the major modification observed is the loss of an entire oligosaccharide chain; we also demonstrate that there is a modification of terminal sialylation. Carbohydrate-deficient transferrin (CDT) is the result of multiple alterations of glycosylation. These results give a partial explanation to the poor sensitivity of the measurement of CDT and its controversial use as a marker of chronic alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12626412     DOI: 10.1093/glycob/cwg016

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  10 in total

1.  Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series.

Authors:  Scott H Stewart; Susana Comte-Walters; Emily Bowen; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

2.  Gender-related variations in iron metabolism and liver diseases.

Authors:  Duygu D Harrison-Findik
Journal:  World J Hepatol       Date:  2010-08-27

3.  Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease.

Authors:  Scott H Stewart; Adrian Reuben; Raymond F Anton
Journal:  Alcohol Alcohol       Date:  2016-10-07       Impact factor: 2.826

4.  Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics.

Authors:  Eric D Dodds; Richard R Seipert; Brian H Clowers; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

Review 5.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

6.  Serum level of sialic acid (SA) and carbohydrate-deficient transferrin (CDT) in type 2 diabetes mellitus with microvascular complications.

Authors:  Bogdan Cylwik; Lech Chrostek; Barbara Jakimiuk; Anna Popławska; Maciej Szmitkowski
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

7.  Galectin-3 guides intracellular trafficking of some human serotransferrin glycoforms.

Authors:  Michael C Carlsson; Per Bengtson; Helena Cucak; Hakon Leffler
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

8.  Glycosylation defects underlying fetal alcohol spectrum disorder: a novel pathogenetic model. "When the wine goes in, strange things come out" - S.T. Coleridge, The Piccolomini.

Authors:  M Binkhorst; S B Wortmann; S Funke; T Kozicz; R A Wevers; E Morava
Journal:  J Inherit Metab Dis       Date:  2011-12-02       Impact factor: 4.982

Review 9.  Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry.

Authors:  Jose L Luque-Garcia; Thomas A Neubert
Journal:  J Chromatogr A       Date:  2006-12-12       Impact factor: 4.759

10.  Screening for abnormal glycosylation in a cohort of adult liver disease patients.

Authors:  Jos C Jansen; Bart van Hoek; Herold J Metselaar; Aad P van den Berg; Fokje Zijlstra; Karin Huijben; Monique van Scherpenzeel; Joost P H Drenth; Dirk J Lefeber
Journal:  J Inherit Metab Dis       Date:  2020-07-17       Impact factor: 4.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.